Free Shipping on Orders Over $149 — Lab-Tested 99%+ Purity — USA Shipped

KLOW 80mg - Research Peptide
Weight Management 80mg

KLOW

$210.00 In Stock

Proprietary peptide blend for neuroprotection and mitochondrial support research.

≥98%
HPLC Purity
COA
Included
USA
Based Supplier

Description

Proprietary peptide blend for neuroprotection and mitochondrial support research.

KLOW is a proprietary multi-peptide blend formulated at 80mg to support neuroprotection and mitochondrial function research. The blend is designed to target complementary pathways including PGC-1alpha activation (a master regulator of mitochondrial biogenesis), anti-inflammatory cytokine suppression, and oxidative stress reduction. The multi-component approach aims to address the interconnected nature of neuroinflammation and mitochondrial dysfunction, where impaired energy production and elevated reactive oxygen species form a feedback loop implicated in cognitive decline models. Research into combination peptide formulations suggests that multi-target strategies may produce synergistic effects not achievable with single-compound protocols, as demonstrated in preclinical studies examining neuroprotective cocktails (Russo et al., Frontiers in Neuroscience, 2018). The PGC-1alpha activation component is particularly relevant given research indicating that this transcriptional coactivator drives expression of antioxidant enzymes (SOD2, catalase) alongside mitochondrial respiratory chain genes, providing both metabolic and protective benefits simultaneously. Compared to single-peptide neuroprotective agents like Semax or Selank, a multi-target blend approach may engage both inflammatory and metabolic dimensions of neuronal stress. The proprietary nature of this formulation means individual component ratios are optimized for combined activity rather than standalone use. Store the lyophilized blend at -20C; reconstitute with bacteriostatic water and refrigerate at 2-8C, using within 21 days. This blend is studied by integrative neuroscience laboratories, mitochondrial medicine researchers, and institutions investigating multi-pathway approaches to cognitive resilience.

This product is supplied as a lyophilized powder and is intended for laboratory and research use only. Not for human consumption. Each vial contains 80mg of research-grade material.

Research Applications

  • Mitochondrial support and PGC-1alpha activation
  • Anti-inflammatory cytokine suppression
  • Cognitive decline and brain fog research
  • Oxidative stress conditions

Specifications

Size
80mg
Purity
≥98% (HPLC)
Form
Lyophilized Powder

Storage & Handling

  • Long-term storage: -20°C in a sealed, light-protected container
  • Short-term storage: 2-8°C (refrigerated) for up to 30 days
  • Reconstituted: Store at 2-8°C and use within 30 days
  • Avoid: Repeated freeze-thaw cycles, direct sunlight, and moisture exposure
  • Reconstitution: Use bacteriostatic water or sterile water for injection

Frequently Asked Questions

What is KLOW and how does it work?
KLOW is a proprietary multi-peptide blend formulated for neuroprotection and mitochondrial support research. The blend targets multiple pathways simultaneously, including PGC-1alpha activation (a master regulator of mitochondrial biogenesis), anti-inflammatory cytokine modulation, and oxidative stress reduction. This multi-target approach allows researchers to study synergistic effects across metabolic and neurological pathways.
What research has been done on KLOW's component peptides?
While KLOW itself is a proprietary formulation, its individual component peptides have been studied extensively. Published research supports the roles of mitochondrial-targeting peptides in PGC-1alpha activation (Nature Reviews Molecular Cell Biology) and anti-inflammatory peptides in cytokine suppression models. The blend approach reflects emerging research on polypharmacology — using multiple compounds to achieve synergistic outcomes.
How does KLOW compare to single-peptide mitochondrial compounds?
Unlike single-compound approaches such as SS-31 (Elamipretide) or MOTS-C, KLOW combines multiple peptides targeting different aspects of mitochondrial function and neuroprotection. Single peptides typically address one pathway (e.g., cardiolipin stabilization for SS-31, AMPK activation for MOTS-C), while KLOW's blend is designed for researchers studying multi-pathway interactions and synergistic effects.
What is the recommended reconstitution protocol for KLOW?
For this 80mg vial, reconstitute with 4mL of bacteriostatic water to yield a 20mg/mL solution. Due to the larger peptide content, dissolution may take 5-10 minutes. Add water slowly along the vial wall and allow the blend to dissolve naturally without shaking. Store reconstituted solution at 2-8°C and use within 30 days.
What purity testing is performed on KLOW?
As a multi-peptide blend, KLOW undergoes component-level HPLC testing to verify each peptide meets the minimum 98% purity standard. The final blend is then tested for overall composition accuracy via mass spectrometry. Additional testing includes endotoxin levels (LAL method), sterility screening, and peptide content verification. A comprehensive Certificate of Analysis (COA) is provided.

Related Products

GLP3-R (Retatrutide) 30mg
30mg In Stock

GLP3-R (Retatrutide)

Triple-agonist research peptide targeting GIP, GLP-1, and glucagon receptors for advanced metabolic studies.

$399.00
Cagrilintide 10mg
10mg In Stock

Cagrilintide

Long-acting synthetic amylin analogue for obesity and metabolic research.

$289.00
Tesamorelin 10mg
10mg In Stock

Tesamorelin

Synthetic GHRH analogue studied for visceral fat reduction and metabolic health.

$109.00

Research Use Only. This product is not intended for human consumption, therapeutic use, or diagnostic purposes. All peptides sold by Elyte Peptides are strictly for in-vitro research and laboratory use. By purchasing, you agree to use this product in compliance with all applicable laws and regulations.